Meatable

Executive Summary

Meatable is a Dutch cultivated meat company leveraging a proprietary stem-cell technology, Opti-Ox™, licensed from bit.bio, to produce real muscle and fat cells for ground meat products. Founded in 2020 and currently in the preclinical stage, the company claims its platform achieves 16× faster production than livestock, 100% cell-type efficiency, and superior feed conversion. This technology aims to deliver sustainable, real-meat alternatives at scale, targeting the growing demand for ethical and environmentally friendly protein sources. While Meatable has yet to commercialize its products, its novel approach addresses key challenges in cultivated meat production—speed, efficiency, and cost—potentially positioning it as a disruptor in the alternative protein space. The company operates from Leiden, Netherlands, with a team of 50-200 employees and has not publicly disclosed its total funding or valuation.

Upcoming Catalysts (preview)

• 2027Regulatory Approval in Singapore or the US40% success
• Q4 2026Completion of Pilot Production Facility60% success
• Q3 2026Strategic Partnership or Series B Funding70% success